Oryzon Genomics S.A. (BME:ORY)
3.100
-0.025 (-0.80%)
Feb 6, 2026, 4:19 PM CET
Oryzon Genomics Employees
Oryzon Genomics had 47 employees as of June 30, 2025. The number of employees did not change since the number was reported on December 31, 2024.
Employees
47
Change
n/a
Growth
n/a
Revenue / Employee
€156,570
Profits / Employee
€58,639
Market Cap
246.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 47 | 0 | - |
| Dec 31, 2024 | 47 | 1 | 2.17% |
| Dec 31, 2023 | 46 | 2 | 4.78% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 1 | 1.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 23,800 |
| Laboratorios Farmaceuticos Rovi | 2,188 |
| Almirall | 2,084 |
| Atrys Health | 2,016 |
| Faes Farma | 1,894 |
| Clínica Baviera | 1,847 |
| Laboratorio Reig Jofre | 1,426 |
| Prim, S.A. | 902 |
Oryzon Genomics News
- 6 months ago - ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025 - Benzinga
- 9 months ago - Oryzon Genomics S.A. GAAP EPS of -$0.03 - Seeking Alpha
- 1 year ago - Oryzon Genomics S.A. GAAP EPS of -$0.02 - Seeking Alpha
- 1 year ago - ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders' Meeting - Benzinga